Cargando…
Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing
Although nintedanib is overwhelmingly prescribed to elderly patients, this is the first study to demonstrate that ageing does not impact the efficacy of nintedanib. This study sheds light on the utility of aged animal models in pulmonary fibrosis. https://bit.ly/3zA9RC5
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613836/ https://www.ncbi.nlm.nih.gov/pubmed/34531276 http://dx.doi.org/10.1183/13993003.00759-2021 |
| _version_ | 1784603726620655616 |
|---|---|
| author | Kato, Kosuke Shin, Yoon-Joo Palumbo, Sunny Papageorgiou, Ioannis Hahn, Seongmin Irish, Joseph D. Rounseville, Skye P. Krafty, Robert T. Wollin, Lutz Sauler, Maor Hecker, Louise |
| author_facet | Kato, Kosuke Shin, Yoon-Joo Palumbo, Sunny Papageorgiou, Ioannis Hahn, Seongmin Irish, Joseph D. Rounseville, Skye P. Krafty, Robert T. Wollin, Lutz Sauler, Maor Hecker, Louise |
| author_sort | Kato, Kosuke |
| collection | PubMed |
| description | Although nintedanib is overwhelmingly prescribed to elderly patients, this is the first study to demonstrate that ageing does not impact the efficacy of nintedanib. This study sheds light on the utility of aged animal models in pulmonary fibrosis. https://bit.ly/3zA9RC5 |
| format | Online Article Text |
| id | pubmed-8613836 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86138362021-11-26 Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing Kato, Kosuke Shin, Yoon-Joo Palumbo, Sunny Papageorgiou, Ioannis Hahn, Seongmin Irish, Joseph D. Rounseville, Skye P. Krafty, Robert T. Wollin, Lutz Sauler, Maor Hecker, Louise Eur Respir J Agora Although nintedanib is overwhelmingly prescribed to elderly patients, this is the first study to demonstrate that ageing does not impact the efficacy of nintedanib. This study sheds light on the utility of aged animal models in pulmonary fibrosis. https://bit.ly/3zA9RC5 European Respiratory Society 2021-11-25 /pmc/articles/PMC8613836/ /pubmed/34531276 http://dx.doi.org/10.1183/13993003.00759-2021 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Agora Kato, Kosuke Shin, Yoon-Joo Palumbo, Sunny Papageorgiou, Ioannis Hahn, Seongmin Irish, Joseph D. Rounseville, Skye P. Krafty, Robert T. Wollin, Lutz Sauler, Maor Hecker, Louise Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| title | Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| title_full | Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| title_fullStr | Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| title_full_unstemmed | Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| title_short | Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| title_sort | leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing |
| topic | Agora |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613836/ https://www.ncbi.nlm.nih.gov/pubmed/34531276 http://dx.doi.org/10.1183/13993003.00759-2021 |
| work_keys_str_mv | AT katokosuke leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT shinyoonjoo leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT palumbosunny leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT papageorgiouioannis leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT hahnseongmin leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT irishjosephd leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT rounsevilleskyep leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT kraftyrobertt leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT wollinlutz leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT saulermaor leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing AT heckerlouise leveragingageingmodelsofpulmonaryfibrosistheefficacyofnintedanibinageing |